Skip to main content
VCbacked
Log inGet Started

Stingray Therapeutics

Houston, United States

Stingray Therapeutics is a biotech company that develops immunotherapies to treat various types of cancer.

$6.6M raised
Mar 2023
Venture - Series Unknown
BiotechnologyHealth CareTherapeutics

Top Investors

Propel(X)Newchip AcceleratorHealth WildcattersTHE CATALYTIC IMPACT FOUNDATION (CIF)

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Stingray Therapeutics

How much funding has Stingray Therapeutics raised?
Stingray Therapeutics has raised $6.6M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in March 2023.
Who are Stingray Therapeutics's investors?
Stingray Therapeutics's investors include Propel(X), Newchip Accelerator, Health Wildcatters, THE CATALYTIC IMPACT FOUNDATION (CIF).
Where is Stingray Therapeutics headquartered?
Stingray Therapeutics is headquartered in Houston, United States.
What does Stingray Therapeutics do?
Stingray Therapeutics is a biotech company that develops immunotherapies to treat various types of cancer.
What stage is Stingray Therapeutics at?
Stingray Therapeutics is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Stingray Therapeutics — Funding & Investors." VCBacked, March 31, 2023, https://www.vcbacked.co/company/stingray-therapeutics. Accessed June 4, 2026.
APA
VCBacked. (2023). Stingray Therapeutics — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/stingray-therapeutics
Wikipedia (cite web)
{{cite web |title=Stingray Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/stingray-therapeutics |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong